Crescendo Bioscience Receives Accreditation From the College of American Pathologists
5/1/2013 11:41:59 AM
More...
|
Crescendo Bioscience Announces Laboratory Clearance for Use of Vectra® DA in New York State
4/18/2013 11:21:59 AM
More...
|
Crescendo Bioscience Announces Laboratory Clearance for Use of Vectra® DA in New York
4/18/2013 8:20:47 AM
More...
|
Crescendo Bioscience to Present Data on the Use of Vectra™ DA in Assessing Response to Treatments at Crescendo Bioscience/Associate Rheumatology Health Professional Annual Meeting
11/12/2012 7:59:50 AM
More...
|
Crescendo Bioscience Names Industry Leader Oscar Segurado, M.D., Ph.D., Chief Medical Officer
6/13/2012 9:25:15 AM
More...
|
Crescendo Bioscience's Vectra™ DA Test Indicates Remission in Rheumatoid Arthritis Patients
6/6/2012 11:44:17 AM
More...
|
Crescendo Bioscience Pockets $56 Million and Gives Buyout Option to Myriad Genetics, Inc. (MYGN)
9/9/2011 8:16:24 AM
More...
|
Studies Show Crescendo Bioscience’s Vectra(TM) DA Can Track Early Response to Rheumatoid Arthritis Therapy and Predict Joint Damage at the Molecular Level
5/25/2011 10:56:03 AM
More...
|
Crescendo Bioscience Announces the U.S. Launch of the First Multi-Biomarker Blood Test for Rheumatoid Arthritis Disease Activity
11/8/2010 10:32:22 AM
More...
|